Air, Freight News

UTi’s New LCL Pharma Offering Sets Sail

[ November 20, 2015   //   ]

Unveiled in October October at the Port2Port Cold Chain Forum in Tel Aviv, where it won the conference’s innovation award, UTi Worldwide Inc. has launched a new temperature-controlled partial shipping service for the pharmaceutical industry, the first to connect Belgium and Israel.
UTi’s “LCL Pharma” service provides a cost-effective alternative to airfreight for pharmaceuticals and other healthcare-related, temperature-sensitive products. It allows clients to make Less than
Container Load (LCL) shipments without compromising quality standards.
Temperature-sensitive freight can be collected from across Europe and delivered to UTi’s GDP Certified Pharma Hub near Brussels. The hub is configured to run 15 ° C to 25 ° C but also has 2 ° C to 8 ° C zones and a dedicated Pharma DG area, enabling additional routes and services to be added in the future. Real-time monitoring and control ensures that cool chain integrity is maintained throughout its onward journey, even through customs.
“We are always looking at how innovative supply chain solutions can deliver better results for our clients and their patients,” said Phil Abbate, UTi Global Vice President, Pharmaceutical & Healthcare. “Through our ‘pharma network of excellence’ we continue to push the envelope in seeking out cost-effective alternatives that address the high cost of shipping perishables. Our new LCL solution is just one example of this, providing our healthcare clients with a seamless, temperature-controlled service, thus allowing them to move goods more efficiently by shipping smaller volumes on a regular schedule.”
UTi New LCL award

Tags: ,